I like your post. There is no reason for anyone to spew on

New Post Public Reply Private Reply Replies (0) Message Board
Splithappens Optimistic Trader #14865
301
I like your post. There is no reason for anyone to spew on either side of the "pump/dump" spectrum.

No CEO in their right mind will tell a shareholder of a RS prior to it happening. That is insider information and must be announced publicly only (so surf asked a question that he should have not asked). I got hit with a RS on another ticker 3 months ago and I will not fault the CEO, I moved on and still watch that ticker for trading opportunities. These are the rules of the game and anyone who gets angry at the company and its execs. shouldnt be trading. Those who bash are doing it with some factual past performances by the company and/or the execs. The only problem with that is, "Past performance is no guarantee of future results."

As far as unicorns and rainbows. Also unrealistic and easily spotted. Unfortunately pumpers are painting pictures of the future and their belief of the potential. This is something each individual needs to decifer on their own through DD. Anything can happen going forward, good or bad.

I believe some of the stuff being spewed on IHUB is shameful. I.E., I AM RAM is a shareholder of UOIP and believes in it while he/she with sidekick sexy are bashing SFOR. FYI, UOIP is under "caveot emptor" and hasnt filed fins. in approx. 2 years. This is the double standard that is B.S.

When Dr.E goes on rants and posts endlessly, to me that is sad. All those posts become giborish simply because he is diluting his own point with too much minutiae. Posting less and to the point is more powerful and carries more meaning.

I take it all with a grain of salt and ALL trading sites have an entertainment value to them. But i do look for info that I can fact check and consider myself to be in the middle of the spetrum but am always an "optimistic trader" regardless of ticker symbol.

GL.

IMO.

Zerify Inc (ZRFY) Stock Research Links

ZRFY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Roborock Fuels Market Surge with 27.6% Revenue Boost

Updated Category News Views 1

Roborock's Rocket-Like Ascent in Global Markets Call me impressed, but Roborock is really hitting its stride. The company's been on a tear, pulling in RMB 10.084 billion during the first half of 2026—a remarkable 27.6% bump from last year. Not just content with the revenue surge, they also saw net profits jump 45.6%, making it pretty clear that they're not just playing...

Continue Reading
Asia-Pacific Media Forum Eyes Future Growth Strategies

Updated Category News Views 2

Media Heavyweights Converge in Shenzhen Picture this: Over 400 media moguls from the Asia-Pacific region, huddled together in Shenzhen under that blazing September sun. What for? They're on a mission, inspecting China's shifting landscape, hunting down fresh growth avenues in the Guangdong-Hong Kong-Macao Greater Bay Area. It kicks off within the walls of the Asia-Pacific...

Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

Updated Category News Views 3

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

Continue Reading
Mermaid Folklore Meets Revolution in New Short Film

Updated Category News Views 2

A Sea Haunting Like No Other Ever feel like history's forgotten tales deserve a fresh spin? Well, this one's shaking it up! Hoyt Dwyer, an Atlanta filmmaker, flips the script on a lesser-known bit from the American Revolution. Yeah, we're talking about Hessian soldiers and sirens here. Just hang on to your hats because this ain't your typical historical retelling. A...

Continue Reading
See's Candies Data Breach Spurs Legal Scrutiny

Updated Category News Views 12

Data Breach Hits See's Candies Hard Amidst Ransomware Attack Alright, folks, here's a not-so-sweet tale to kick off your day — See's Candies has found itself in a bit of a pickle. A ransomware attack, the nasty kind that makes you double-check your locks and your passwords, has reportedly exposed the personal data of its customers and employees. We're talking names,...

Continue Reading
Creality Rolls Out K3, SPARKX i8 at IFA 2026

Updated Category News Views 7

Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....

Continue Reading
Media Forum Spotlights Asia-Pacific Cooperation

Updated Category News Views 3

The Opening Scene: A Gathering with Purpose Well, here we go, diving right into the latest shindig in Shenzhen at the Asia-Pacific Media Forum. Held in China's Guangdong province, they've rounded up over 400 reps from every corner of the globe, all chewing over one key theme: "Building a Path to Shared Prosperity for the Asia-Pacific Community." You could say it's a step...

Continue Reading
EyePoint Stumbles: Legal Eagles Circle Post-Trial Flop

Updated Category News Views 2

EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...

Continue Reading
Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins

Updated Category News Views 3

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

Continue Reading
Changhong's IFA 2026 Showcase: AI, Culture & Localization

Updated Category News Views 3

Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover Space-ng's New Computer Vision Solutions

Updated Category News Views 125

Introducing Space-ng's Innovative Vision System Space-ng is excited to present a revolutionary Hardware Development Kit (HDK) and a Software Development Kit (SDK) tailored for their renowned Sol3 Vision System. This initiative embodies a commitment to affordable, rugged, and air-cooled technology suitable for space applications. The HDK is designed for rapid prototyping,...

Continue Reading
iOnctura Advances Treatment Options for Uveal Melanoma Patients

Updated Category News Views 182

iOnctura Reports Significant Clinical Progress in Uveal Melanoma iOnctura, a clinical-stage biopharmaceutical company, has recently unveiled critical advancements in its efforts to combat uveal melanoma, a rare form of eye cancer that often presents significant treatment challenges. The company has completed its Phase I DIONE-01 study, showcasing encouraging clinical...

Continue Reading
Spyre Therapeutics Progresses with SPY001 for IBD Treatment

Updated Category News Views 115

Spyre Therapeutics Reports Encouraging Phase 1 Trial Data Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company, has recently released promising interim results from its Phase 1 trial of SPY001, an innovative half-life extended monoclonal antibody aimed at treating inflammatory bowel disease (IBD). The study indicates that SPY001 was well...

Continue Reading
Understanding the University of Phoenix Tuition Guarantee

Updated Category News Views 194

Understanding the University of Phoenix Tuition Guarantee Fixed tuition and new transparency initiatives support adult learners in planning educational expenses. University of Phoenix is enhancing its commitment to clear and consistent tuition costs through its Tuition Guarantee initiative. This program ensures that students benefit from a locked-in tuition rate from the...

Continue Reading
Halper Sadeh Investigates Shareholder Rights for IPXX, PWUP, DECA, TTNP

Updated Category News Views 38

Halper Sadeh LLC Investigates Shareholder Rights Halper Sadeh LLC, a law firm dedicated to protecting investor rights, is currently examining several companies for potential violations of federal securities laws and breaches of fiduciary duties. This investigation focuses on significant firms involved in mergers, with the aim of safeguarding shareholder interests....

Continue Reading